Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5798 EUR | +1.72% | +1.36% | -71.58% |
07-12 | BIOPHYTIS : Invest Securities confirms its recommendation | CF |
07-11 | Biophytis Secures US FDA Approval for Mid-stage Study of Obesity Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-71.58% | 3.27M | |
+20.63% | 127B | |
+23.21% | 117B | |
+25.39% | 27.67B | |
-20.17% | 20.33B | |
-17.08% | 16.79B | |
-18.07% | 15.63B | |
+11.92% | 14.84B | |
-47.70% | 14.65B | |
+58.32% | 14.43B |
- Stock Market
- Equities
- ALBPS Stock
- News Biophytis S.A.
- Biophytis Secures US FDA Approval for Mid-stage Study of Obesity Drug